John R. Hurst

Active 1982–2025

183
Papers
23,891
Citations
75
h-index
164
i10-index

Citations

Citations per year for John R. Hurst1916: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1988: 2 citations1989: 1 citations1990: 2 citations1991: 1 citations1992: 4 citations1996: 3 citations1997: 1 citations1998: 1 citations1999: 2 citations2000: 2 citations2001: 3 citations2003: 5 citations2004: 3 citations2005: 7 citations2006: 41 citations2007: 66 citations2008: 47 citations2009: 45 citations2010: 48 citations2011: 98 citations2012: 151 citations2013: 149 citations2014: 156 citations2015: 116 citations2016: 122 citations2017: 137 citations2018: 155 citations2019: 510 citations2020: 653 citations2021: 849 citations2022: 846 citations2023: 698 citations2024: 1,126 citations2025: 479 citations2026: 12 citations1917–1983: no citations, so these years are not shown1987: no citations, so this year is not shown1993–1995: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited Kingdom: 1,431 citing papers, 15.1% of this breakdownUnited States: 1,415 citing papers, 15% of this breakdownChina: 544 citing papers, 5.8% of this breakdownItaly: 475 citing papers, 5% of this breakdownSpain: 444 citing papers, 4.7% of this breakdownGermany: 421 citing papers, 4.4% of this breakdownCanada: 412 citing papers, 4.4% of this breakdownAustralia: 359 citing papers, 3.8% of this breakdownNetherlands: 359 citing papers, 3.8% of this breakdownFrance: 237 citing papers, 2.5% of this breakdownBelgium: 190 citing papers, 2% of this breakdownSweden: 186 citing papers, 2% of this breakdown
0%15.1%Other 31.5%

Fields

  • Medicine84.3%
  • Biochemistry, Genetics and Molecular Biology4%
  • Immunology and Microbiology2.6%
  • Computer Science1.6%
  • Health Professions1.4%
  • Environmental Science1.3%
  • Other4.8%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research17.4%
  • Respiratory Support and Mechanisms6.1%
  • Long-Term Effects of COVID-196%
  • Asthma and respiratory diseases5%
  • Respiratory and Cough-Related Research3.2%
  • COVID-19 Clinical Research Studies2.9%
  • Other59.4%

Coauthors

All papers

Open in search
  1. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,979

  2. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew Davies, Anthony De Soyza, J R Geddes, William Greenhalf, Neil Greening, Liam G. Heaney, Simon Heller, Luke Howard, Joseph Jacob, Gísli Jenkins, Janet M. Lord, William D‐C Man, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Malcolm G. Semple, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Ryan S. Thwaites, Andrew Briggs, Annemarie B Docherty, S Kerr, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Mathew Thorpe, Bang Zheng, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, K Poinasamy, Betty Raman, Ewen M. Harrison, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, R Adrego, L A Aguilar Jimenez, Shazaad Ahmad, Nafees Haider, Rizwan Ahmed, N Ahwireng, Mark Ainsworth, B Al-Sheklly, A Alamoudi, Mohammad Ali, M Aljaroof, AM All, Louise Allan, R Allen, L. Allerton, Lynne Allsop, P. Almeida, Doris Altmann, Maria Alvarez Corral, S Amoils, Debra Anderson, Chrystalina A. Antoniades, G Arbane, A. Arias, Chérie Armour and 906 more - The Lancet Respiratory Medicine 2022 cited by 424

  3. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janet M. Lord, Gerry P McCann, Stefan Neubauer, Peter Openshaw, Dhruv Parekh, Paul Pfeffer, Najib M. Rahman, Betty Raman, Matthew Richardson, Matthew Rowland, Malcolm G. Semple, Ajay M. Shah, Sally Singh, Aziz Sheikh, David Thomas, Mark Toshner, James D. Chalmers, Ling‐Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Louise V. Wain, Christopher E. Brightling, Kathryn M. Abel, Huzaifa Adamali, Davies Adeloye, O Adeyemi, Famous O. Adeyemi, Shazaad Ahmad, Rizwan Ahmed, Mark Ainsworth, B Al-Sheklly, Asma Khalid Alamoudi, M Aljaroof, Louise Allan, R Allen, A Alli, Doris Altmann, Debra Anderson, Michele Andrews, Adrienn Angyal, Chrystalina A. Antoniades, G Arbane, Chérie Armour, Natalie Armstrong, Lará Armstrong, H Arnold, David Arnold, Mark Ashworth, Andrew Ashworth, H Assefa-Kebede, Philip A. Atkin, H. Atkins, Amy Atkins, Raminder Aul, Cristina Avram, Rob Baggott, David Baguley, J. Kenneth Baillie, S. Bain, M Bakali, M Bakau, Eileen Baldry, David Baldwin, Clive Ballard, J. Bambrough, Ruth E Barker, Shaney Barratt, Fiona Barrett, D Basire and 680 more - The Lancet Respiratory Medicine 2021 cited by 659

  4. Cardiovascular disease and COPD: dangerous liaisons?

    Authors: , , - European Respiratory Review 2018 cited by 406

  5. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 cited by 337

  6. Improving lung health in low-income and middle-income countries: from challenges to solutions

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cherian Varghese, Claus Vogelmeier, Paul Walker, Heather J. Zar, Guy B. Marks - The Lancet 2021 cited by 471

  7. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19

    Authors: , , , , , , , , , , , , , , , - Thorax 2020 cited by 914

  8. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study

    Authors: , , , , , , , , , , , , , , , , , , , - BMJ Open 2023 cited by 126

  9. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

    Authors: , , , , , , , , , , , , , , - European Respiratory Journal 2017 cited by 681

  10. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation

    Authors: , , , , , , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 633

  11. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

    Authors: , , , , , , , - European Respiratory Journal 2015 cited by 568

  12. Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD

    Authors: , , , , - CHEST Journal 2009 cited by 518

  13. The unmet global burden of COPD

    Authors: , - Global Health 2018 cited by 438

  14. Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease

    Authors: , , , , - American Journal of Respiratory and Critical Care Medicine 2004 cited by 706

  15. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life

    Authors: , , , , , , - European Journal of Internal Medicine 2020 cited by 207

  16. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

    Authors: , , , , , , , - Respiratory Research 2022 cited by 133

  17. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Declan P. O’Regan, Jonathan Fuld, Jonathan Weir‐McCall, Dhruv Parekh, Rick Steeds, Krisnah Poinasamy, Dan J Cuthbertson, Graham J. Kemp, Malcolm G. Semple, Alex Horsley, Chris Miller, Caitlin E. O’Brien, Ajay M. Shah, Amedeo Chiribiri, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish McAuley, Marco Sereno, Ruth Saunders, Linzy Houchen‐Wolloff, Neil Greening, Charlotte E. Bolton, Jeremy Brown, Gourab Choudhury, Nawar Diar Bakerly, Nicholas Easom, Carlos Echevarria, Michael Marks, John R. Hurst, Mark G. Jones, Dan Wootton, Trudie Chalder, Melanie J. Davies, Anthony De Soyza, John Geddes, William Greenhalf, Luke Howard, Joseph Jacob, William D‐C Man, Peter Openshaw, Joanna C. Porter, Matthew Rowland, J. T. Scott, Sally Singh, David Thomas, Mark Toshner, Keir Lewis, Liam G. Heaney, Ewen M. Harrison, Steven Kerr, Annemarie B Docherty, Nazir Lone, Jennifer K Quint, Aziz Sheikh, Bang Zheng, Gísli Jenkins, Eleanor Cox, Susan Francis, Mark Halling‐Brown, James D. Chalmers, John P. Greenwood, Sven Plein, Paul Hughes, A. A. Roger Thompson, Sarah Rowland‐Jones, James M Wild, Matthew Kelly, Thomas A. Treibel, Steven Bandula and 941 more - The Lancet Respiratory Medicine 2023 cited by 54

  18. Disease Progression Modeling in Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 99

  19. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions

    Authors: , , , , , , , , - European Respiratory Journal 2018 cited by 254

  20. British Thoracic Society Guideline for bronchiectasis in adults

    Authors: , , , , , , , , , , , , , , , , , , , , , , - BMJ Open Respiratory Research 2018 cited by 605

  21. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , - European Respiratory Review 2022 cited by 77

  22. Cardiovascular disease and risk in COPD: a state of the art review

    Authors: , , , , , - Expert Review of Cardiovascular Therapy 2024 cited by 76

  23. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 76

  24. Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis

    Authors: , , , , , , , , , , - European Respiratory Review 2020 cited by 148